{"transactions":[{"id":2329637,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129034,"kind":"person","name":"Federoff Howard J.","position":1,"cik":"0001857261","reported_name":"Federoff Howard J.","relationship":{"director":true,"officer":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-18T01:00:28.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":413700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in 36 substantially equal monthly installments from the grant date."}],"balance_after":413700,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":413700},"source":{"system":"sec-edgar","filing":"0001140361-22-009982","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009982/form4.xml","form_type":"4/A","original_submission_date":"2022-03-15"}},{"id":2334480,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129034,"kind":"person","name":"Federoff Howard J.","position":1,"cik":"0001857261","reported_name":"Federoff Howard J.","relationship":{"director":true,"officer":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-16T01:34:25.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":413700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":413700,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":413700},"source":{"system":"sec-edgar","filing":"0001140361-22-009662","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009662/form4.xml","form_type":"4"}},{"id":2744567,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129034,"kind":"person","name":"Federoff Howard J.","position":1,"cik":"0001857261","reported_name":"Federoff Howard J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2021-04-21T00:16:02.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":597253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in full upon the occurrence of the first approval by the Food and Drug Administration of an investigational new drug application in connection with that certain license among the Issuer, Factor Biosciences Therapeutics Limited and Novellus Therapeutics Limited, subject to continued service through such vesting date."}],"balance_after":597253,"derivative":{"exercise_price":7.94,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":597253},"source":{"system":"sec-edgar","filing":"0001140361-21-013551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121013551/form4.xml","form_type":"4"}},{"id":2744566,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":129034,"kind":"person","name":"Federoff Howard J.","position":1,"cik":"0001857261","reported_name":"Federoff Howard J.","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2021-04-21T00:16:02.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":2627915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over four years, with 656,979 shares vesting on April 16, 2022, 54,748 shares vesting on the sixteenth day of each month from May 2022 through March 2025, and the remaining 54,756 shares vesting on April 16, 2025, subject to continued service through each vesting date."}],"balance_after":2627915,"derivative":{"exercise_price":7.94,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":2627915},"source":{"system":"sec-edgar","filing":"0001140361-21-013551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121013551/form4.xml","form_type":"4"}}]}